Talanx (XTRA:TLX) is drawing fresh attention after reporting half year 2026 earnings. Net income reached €1,499 million and earnings per share from continuing operations were €5.8, compared with the prior year period.
See our latest analysis for Talanx.
The stronger half year 2026 earnings have come alongside firm share price momentum for Talanx, with a 30 day share price return of 5.82% and a 90 day return of 12.99%. Over longer horizons, total shareholder returns of 115.85% over three years and 277.61% over five years point to a stock that has already rewarded patient holders. Current moves may reflect investors reassessing both growth potential and risk.
If these results have you rethinking your portfolio, it can help to see what else the market is pricing in. Now could be a good time to broaden your search with 113 top founder-led companies
Some investors now see Talanx as a quality compounder that deserves a richer price tag, while others worry the recent run already reflects the good news. The valuation numbers help show which side the evidence backs.
The most followed narrative puts fair value for Talanx at €126, slightly above the last close of €121.8, which suggests only a modest valuation gap.
The analysts have a consensus price target of €126.0 for Talanx based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €158.0, and the most bearish reporting a price target of just €94.0.
Analysts are not just adjusting headline targets; they are incorporating specific paths for revenue, earnings and margins that need to align very closely. Curious which assumptions need to hold for that fair value to make sense.
Result: Fair Value of €126 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, you still need to consider that currency pressure on international earnings and higher acquisition integration costs could squeeze margins and challenge the current Talanx narrative.
Find out about the key risks to this Talanx narrative.
If this mainly upbeat read on Talanx leaves you curious, take a closer look at the underlying data and test the story for yourself. To see what investors currently view as the key positives, review the 5 key rewards
If Talanx has sharpened your focus, do not stop here. A few minutes exploring targeted stock ideas could highlight opportunities that fit your style.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com